Literature DB >> 17387557

Laparoscopic vertical sleeve gastrectomy for morbid obesity. The future procedure of choice?

Eldo E Frezza1.   

Abstract

I report the general experience of performing sleeve gastrectomy defined as "a partial gastrectomy that results in removal of most of the stomach," as a first-stage procedure for morbidly and super-obese people. I also explore its potential as a single procedure evaluating its advantages and disadvantages. This procedure is designed to reduce the size of the stomach and its distention, whereby the patient feels full sooner and their appetite is decreased. Some posit-increased satiety results from the decreased ghrelin, secreted by the fundus, which is resected during this procedure. The advantages of sleeve gastrectomy are as follows: the stomach is reduced without loss of function, pyloric preservation prevents dumping, it requires only 1 day in the hospital, it provides an effective first-stage procedure for super-obese patients, it is useful in patients with disorders such as anemia or Crohn's disease, which preclude intestinal bypass, it can be performed laparoscopically, even in patients who weigh over 500 lbs, no band adjustment is required, it does not result in malabsorption, and it provides a good educational teaching base for doctors lacking experience in the treatment of gastric ulcers. The disadvantages include the risk of stapling complications and its irreversibility.

Entities:  

Mesh:

Year:  2007        PMID: 17387557     DOI: 10.1007/s00595-006-3407-2

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  28 in total

1.  Outcome of gastric restriction procedures: weight, psychiatric diagnoses, and satisfaction.

Authors:  P S Powers; A Rosemurgy; F Boyd; A Perez
Journal:  Obes Surg       Date:  1997-12       Impact factor: 4.129

2.  Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents.

Authors:  Ayako Ikezaki; Hiroshi Hosoda; Keiko Ito; Saika Iwama; Naoko Miura; Hisafumi Matsuoka; Chisato Kondo; Masayasu Kojima; Kenji Kangawa; Shigetaka Sugihara
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

Review 3.  New advances in laparoscopic treatment of morbid obesity.

Authors:  Rudolf A Weiner; Ingmar Pomhoff; Markus Schramm; Sylvia Weiner; Rafael Blanco-Engert
Journal:  Surg Technol Int       Date:  2004

4.  Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk patients: initial results in 10 patients.

Authors:  Philippe Mognol; Denis Chosidow; Jean-Pierre Marmuse
Journal:  Obes Surg       Date:  2005-08       Impact factor: 4.129

5.  Laparoscopy-assisted distal gastrectomy for early gastric cancer: is it beneficial for patients of heavier weight?

Authors:  Hirokazu Noshiro; Shuji Shimizu; Eishi Nagai; Kenoki Ohuchida; Masao Tanaka
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

6.  Laparoscopic gastric surgery in a Japanese institution: analysis of the initial 100 procedures.

Authors:  Shuji Shimizu; Hirokazu Noshiro; Eishi Nagai; Akihiko Uchiyama; Masao Tanaka
Journal:  J Am Coll Surg       Date:  2003-09       Impact factor: 6.113

7.  Ghrelin immunoreactivity in human plasma is suppressed by somatostatin.

Authors:  Helene Nørrelund; Troels K Hansen; Hans Ørskov; Hiroshi Hosoda; Masayasu Kojima; Kenji Kangawa; Jørgen Weeke; Niels Møller; Jens S Christiansen; Jens Otto L Jørgensen
Journal:  Clin Endocrinol (Oxf)       Date:  2002-10       Impact factor: 3.478

8.  Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity?

Authors:  Felix B Langer; Arthur Bohdjalian; Franz X Felberbauer; Edith Fleischmann; Mir A Reza Hoda; Bernhard Ludvik; Johannes Zacherl; Raimund Jakesz; Gerhard Prager
Journal:  Obes Surg       Date:  2006-02       Impact factor: 4.129

9.  Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans.

Authors:  Fabio Broglio; Peter van Koetsveld Pv; Andrea Benso; Cristina Gottero; Flavia Prodam; Mauro Papotti; Giampiero Muccioli; Carlotta Gauna; Leo Hofland; Romano Deghenghi; Emanuela Arvat; Aart Jan Van Der Lely; Ezio Ghigo
Journal:  J Clin Endocrinol Metab       Date:  2002-10       Impact factor: 5.958

10.  Combined laparoscopic gastric banding and stomach reduction (GBSR): initial experience after 1 year.

Authors:  Eldo E Frezza; Haleigh Herbert; Mitchell S Wachtel
Journal:  Obes Surg       Date:  2008-04-08       Impact factor: 4.129

View more
  49 in total

1.  Are there gender-specific aspects of sleeve gastrectomy-data analysis from the quality assurance study of surgical treatment of obesity in Germany.

Authors:  Christine Stroh; F Köckerling; R Weiner; Th Horbach; K Ludwig; M Dressler; V Lange; P Loermann; S Wolff; U Schmidt; H Lippert; Th Manger
Journal:  Obes Surg       Date:  2012-08       Impact factor: 4.129

2.  Early and mid-term outcomes of single-stage laparoscopic sleeve gastrectomy.

Authors:  Sanket Srinivasa; Laura S Hill; Tarik Sammour; Andrew G Hill; Richard Babor; Habib Rahman
Journal:  Obes Surg       Date:  2010-11       Impact factor: 4.129

Review 3.  Morbid obesity and sleeve gastrectomy: how does it work?

Authors:  Joanna Papailiou; Konstantinos Albanopoulos; Konstantinos G Toutouzas; Christos Tsigris; Nikolaos Nikiteas; George Zografos
Journal:  Obes Surg       Date:  2010-10       Impact factor: 4.129

4.  Short-term effects of sleeve gastrectomy on type 2 diabetes mellitus in severely obese subjects.

Authors:  J Vidal; A Ibarzabal; J Nicolau; M Vidov; S Delgado; G Martinez; J Balust; R Morinigo; A Lacy
Journal:  Obes Surg       Date:  2007-08       Impact factor: 4.129

5.  The First International Consensus Summit for Sleeve Gastrectomy (SG), New York City, October 25-27, 2007.

Authors:  Mervyn Deitel; Ross D Crosby; Michel Gagner
Journal:  Obes Surg       Date:  2008-05       Impact factor: 4.129

6.  Results of sleeve gastrectomy-data from a nationwide survey on bariatric surgery in Germany.

Authors:  Christine Stroh; D Birk; R Flade-Kuthe; M Frenken; B Herbig; S Höhne; H Köhler; V Lange; K Ludwig; R Matkowitz; G Meyer; P Pick; Th Horbach; S Krause; L Schäfer; M Schlensak; E Shang; T Sonnenberg; M Susewind; H Voigt; R Weiner; S Wolff; A M Wolf; U Schmidt; H Lippert; Th Manger
Journal:  Obes Surg       Date:  2009-01-29       Impact factor: 4.129

7.  Nonsurgical treatment of staple line leaks after laparoscopic sleeve gastrectomy.

Authors:  G Casella; E Soricelli; M Rizzello; P Trentino; F Fiocca; A Fantini; F M Salvatori; N Basso
Journal:  Obes Surg       Date:  2009-04-21       Impact factor: 4.129

8.  Comparison of laparoscopic Roux-en-Y gastric bypass with laparoscopic sleeve gastrectomy for morbid obesity or type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.

Authors:  Jian-Fang Li; Dan-Dan Lai; Bin Ni; Kuan-Xue Sun
Journal:  Can J Surg       Date:  2013-12       Impact factor: 2.089

9.  Midterm Clinical Outcomes of Antrum Resection Margin at Laparoscopic Sleeve Gastrectomy for Morbid Obesity.

Authors:  Serdar Yormaz; Huseyin Yılmaz; Ilhan Ece; Farise Yılmaz; Mustafa Sahin
Journal:  Obes Surg       Date:  2017-04       Impact factor: 4.129

10.  Morbid obesity and subsequent pancreatic cancer: pylorus-preserving pancreatoduodenectomy after laparoscopic sleeve gastrectomy.

Authors:  Markus A Küper; Ingmar Königsrainer; Diethard Schmidt; K Michael Kramer; Frank A Granderath; Joachim Schneider; Stefan Löb; Derek Zieker; Jörg T Hartmann; Marty Zdichavsky; Alfred Königsrainer; Björn L D M Brücher
Journal:  Obes Surg       Date:  2008-09-25       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.